ReWalk Robotics Ltd. (LFWD)
Company Description
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa.
The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.
It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors.
The company was formerly known as Argo Medical Technologies Ltd.
ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Country | IL |
IPO Date | Sep 12, 2014 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 80 |
CEO | Lawrence J. Jasinski BS, MBA |
Contact Details
Address: 3 Hatnufa Street Yokneam Illit, IL | |
Website | https://www.rewalk.com |
Stock Details
Ticker Symbol | LFWD |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001607962 |
CUSIP Number | n/a |
ISIN Number | IL0011331076 |
Employer ID | 00-0000000 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Lawrence J. Jasinski BS, MBA | Chief Executive Officer & Director |
Michael A. Lawless | Chief Financial Officer |
Almog Adar | Vice President of Finance & Chief Accounting Officer |
Charles Remsberg | Chief Sales Officer |
Jeannine Lynch | Vice President of Market Access & Strategy |
Judy Kula | Vice President of Customer Service, Human Resources & Business Affairs |
Miri Pariente | Vice President of Operations, Regulatory & Quality |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 07, 2025 | 8-K | Current Report |
Mar 07, 2025 | 424B5 | Filing |
Mar 07, 2025 | 10-K | Annual Report |
Mar 07, 2025 | 8-K | Current Report |
Feb 20, 2025 | 8-K | Current Report |
Feb 14, 2025 | S-1/A | [Amend] Filing |
Feb 11, 2025 | S-1 | Filing |
Jan 14, 2025 | SCHEDULE 13G | Filing |
Jan 13, 2025 | D | Filing |
Jan 13, 2025 | 8-K | Current Report |